Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research

5333 - Association of MMR protein expression and MMR gene mutations in Chinese colorectal cancer patients

Date

20 Oct 2018

Session

Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research

Presenters

Shuang Wang

Citation

Annals of Oncology (2018) 29 (suppl_8): viii14-viii57. 10.1093/annonc/mdy269

Authors

S. Wang1, S. Zhang2, Z. Zeng3, Y. Ou4, M. Han5, J. Guo6, D. Chen7, X. Dong7, J. Hu8, G. Chirn9, W. Shi9, M. Yao8

Author affiliations

  • 1 Department Of Pathology, School of Basic Medical Sciences, Southern Medical University, 510515 - Guangzhou/CN
  • 2 Colorectal-anal Surgery Dept., First Affiliated Hospital of Guangxi Medical University, 530021 - Nanning/CN
  • 3 Medical Oncology, First Affiliated Hospital of Guangxi Medical University, 530021 - Nanning/CN
  • 4 Department Of General Surgery, The First Affiliated Hospital of Clinical Medicine of Guangdong pharmaceutical University, 510080 - Guangzhou/CN
  • 5 Chest Surgery, Jincheng General Hospital, 048000 - Jincheng/CN
  • 6 Medical Oncology, Xingtai people's hospital, 054031 - Xingtai/CN
  • 7 Department Of Pathology, OrigiMed, 200000 - Shanghai/CN
  • 8 Medical Department, OrigiMed, 200000 - Shanghai/CN
  • 9 Department Of Bioinformatics, OrigiMed, 200000 - Shanghai/CN
More

Resources

Abstract 5333

Background

DNA mismatch repair (MMR) deficiency is a genetic abnormality that has important clinical implications related to therapeutic option, familial cancer risk assessment, and checkpoint inhibitor response. It occurs in approximately 15% of colorectal cancers (CRC). Associations between MMR protein expression, microsatellite instability (MSI), and gene mutations remain under investigation.

Methods

Thirty-one FFPE samples from primary CRC patients (pts) were collected for immunohistochemistry (IHC) assay of MMR proteins, PCR-based MSI assay if available and NGS-based panel assay. Genomic alterations including single base substitutions, short and long insertions/deletions, copy number variations, and gene rearrangement were assessed. MSI status were predicted based from NGS data.

Results

Out of 31 sample, 12 CRC were identified as MMR deficiency (dMMR) by IHC including 5 males and 7 females (median age: 66 years), and 19 samples as MMR proficiency (pMMR) including 13 males and 6 females (Median age: 53 years). Eight of the 12 dMMR samples (67%) harbored at least one MMR gene mutations predicted as loss of functions,[u1] including nonsense mutations or truncations in MSH2, MSH6 or MLH1. No MMR gene mutation was detected in any of the 19 pMMR samples (p value<0.001). In addition, 2 BRAF and 6 KRAS hotspot mutations were detected in dMMR samples, and 8 KRAS, 1 BRAF and 1 NRAS mutations in pMMR samples. NGS panel based MSI algorithm successfully predicted the MSI status of all the 31 samples with 100% concordance with the MMR results. Neither copy number variation nor rearrangement was detected. Five pMMR samples were identified as microsatellite stability (MSS) by PCR, 6 dMMR were high level of microsatellite instability (MSI-H), and the rest were failed due to DNA contents.Table: 166P

nMMR gene mutations (n, %)KRAS mutations (n, %)NRAS mutations (n, %)BRAF mutations (n, %)NGS MSI-H status (n, %)
dMMR (IHC)128 (66.7%)6 (50%)0 (0%)2 (16.7%)12 (100%)
pMMR (IHC)190 (0%)8 (42.1%)1 (5.2%)1 (5.2%)0 (0%)

Conclusions

We observed a significant association between MMR deficiency and MMR gene mutations from deep DNA sequencing. The results suggested that CRC pts with MMR gene mutations could be more likely to have dMMR status.

Clinical trial identification

Legal entity responsible for the study

OrigiMed.

Funding

Has not received any funding.

Editorial Acknowledgement

Disclosure

D. Chen, X. Dong, J. Hu, G. Chirn, W. Shi, M. Yao: Employee: OrigiMed. All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.